Cargando…

Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer

BACKGROUND: Utility values are a key component of a cost-utility analysis. The EQ-5D and SF-6D are two commonly used measures for deriving utilities. Of particular importance is assessing the performance of these instruments in terms of validity. OBJECTIVES: This study aimed to compare the performan...

Descripción completa

Detalles Bibliográficos
Autores principales: Yousefi, Mahmood, Najafi, Safa, Ghaffari, Shahram, Mahboub-Ahari, Alireza, Ghaderi, Hossein
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Kowsar 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939232/
https://www.ncbi.nlm.nih.gov/pubmed/27437122
http://dx.doi.org/10.5812/ircmj.23556
_version_ 1782441977528188928
author Yousefi, Mahmood
Najafi, Safa
Ghaffari, Shahram
Mahboub-Ahari, Alireza
Ghaderi, Hossein
author_facet Yousefi, Mahmood
Najafi, Safa
Ghaffari, Shahram
Mahboub-Ahari, Alireza
Ghaderi, Hossein
author_sort Yousefi, Mahmood
collection PubMed
description BACKGROUND: Utility values are a key component of a cost-utility analysis. The EQ-5D and SF-6D are two commonly used measures for deriving utilities. Of particular importance is assessing the performance of these instruments in terms of validity. OBJECTIVES: This study aimed to compare the performance of the EQ-5D and the SF-6D in different states of breast cancer. PATIENTS AND METHODS: This was a cross-sectional study of 163 patients with breast cancer who attended the breast cancer subspecialty clinic affiliated with the breast cancer research center (BCRC) at ACECR, in Tehran, Iran, and were consecutively recruited. Patients completed several questionnaires, including the EQ-5D, SF-36, and general questions regarding their demographic characteristics. Utility values for different states of breast cancer were obtained using predetermined algorithms for the EQ-5D and SF-6D. The distribution of the utility values and the differences between the different states for both instruments were statistically assessed. Furthermore, the agreement between the two instruments was evaluated using intra-class correlation coefficients and Bland-Altman plots. RESULTS: The mean and median EQ-5D utility scores for the total sample were 0.685 and 0.761, respectively. The mean SF-6D utility score for the total sample was 0.653, and the median utility score was 0.640. The mean utility values of the EQ-5D for “state P,” “state R,” “state S,” and “state M” were estimated as 0.674, 0.718, 0.730, and 0.552, respectively. The SF-6D provided mean utility values of 0.638, 0.677, 0.681, and 0.587 for those states. Both instruments assigned statistically significant (P < 0.01) scores for different states. The intra-class correlation for the two measures was 0.677 (95% confidence interval (CI): 0.558 - 0.764). The Bland-Altman plot indicated a better agreement on the higher values and that at higher values, the EQ-5D yields a higher score than the SF-6D; this relationship was reversed at lower values. CONCLUSIONS: Although the two instruments were able to discriminate between various states, the values derived from these instruments were quite different. This distinction could have influenced the conclusions of an economic evaluation. Further research is required to determine which instrument should be used in economic evaluations.
format Online
Article
Text
id pubmed-4939232
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Kowsar
record_format MEDLINE/PubMed
spelling pubmed-49392322016-07-19 Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer Yousefi, Mahmood Najafi, Safa Ghaffari, Shahram Mahboub-Ahari, Alireza Ghaderi, Hossein Iran Red Crescent Med J Research Article BACKGROUND: Utility values are a key component of a cost-utility analysis. The EQ-5D and SF-6D are two commonly used measures for deriving utilities. Of particular importance is assessing the performance of these instruments in terms of validity. OBJECTIVES: This study aimed to compare the performance of the EQ-5D and the SF-6D in different states of breast cancer. PATIENTS AND METHODS: This was a cross-sectional study of 163 patients with breast cancer who attended the breast cancer subspecialty clinic affiliated with the breast cancer research center (BCRC) at ACECR, in Tehran, Iran, and were consecutively recruited. Patients completed several questionnaires, including the EQ-5D, SF-36, and general questions regarding their demographic characteristics. Utility values for different states of breast cancer were obtained using predetermined algorithms for the EQ-5D and SF-6D. The distribution of the utility values and the differences between the different states for both instruments were statistically assessed. Furthermore, the agreement between the two instruments was evaluated using intra-class correlation coefficients and Bland-Altman plots. RESULTS: The mean and median EQ-5D utility scores for the total sample were 0.685 and 0.761, respectively. The mean SF-6D utility score for the total sample was 0.653, and the median utility score was 0.640. The mean utility values of the EQ-5D for “state P,” “state R,” “state S,” and “state M” were estimated as 0.674, 0.718, 0.730, and 0.552, respectively. The SF-6D provided mean utility values of 0.638, 0.677, 0.681, and 0.587 for those states. Both instruments assigned statistically significant (P < 0.01) scores for different states. The intra-class correlation for the two measures was 0.677 (95% confidence interval (CI): 0.558 - 0.764). The Bland-Altman plot indicated a better agreement on the higher values and that at higher values, the EQ-5D yields a higher score than the SF-6D; this relationship was reversed at lower values. CONCLUSIONS: Although the two instruments were able to discriminate between various states, the values derived from these instruments were quite different. This distinction could have influenced the conclusions of an economic evaluation. Further research is required to determine which instrument should be used in economic evaluations. Kowsar 2016-01-20 /pmc/articles/PMC4939232/ /pubmed/27437122 http://dx.doi.org/10.5812/ircmj.23556 Text en Copyright © 2016, Iranian Red Crescent Medical Journal http://creativecommons.org/licenses/by-nc/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
spellingShingle Research Article
Yousefi, Mahmood
Najafi, Safa
Ghaffari, Shahram
Mahboub-Ahari, Alireza
Ghaderi, Hossein
Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
title Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
title_full Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
title_fullStr Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
title_full_unstemmed Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
title_short Comparison of SF-6D and EQ-5D Scores in Patients With Breast Cancer
title_sort comparison of sf-6d and eq-5d scores in patients with breast cancer
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4939232/
https://www.ncbi.nlm.nih.gov/pubmed/27437122
http://dx.doi.org/10.5812/ircmj.23556
work_keys_str_mv AT yousefimahmood comparisonofsf6dandeq5dscoresinpatientswithbreastcancer
AT najafisafa comparisonofsf6dandeq5dscoresinpatientswithbreastcancer
AT ghaffarishahram comparisonofsf6dandeq5dscoresinpatientswithbreastcancer
AT mahboubaharialireza comparisonofsf6dandeq5dscoresinpatientswithbreastcancer
AT ghaderihossein comparisonofsf6dandeq5dscoresinpatientswithbreastcancer